The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2023 | The importance of the MDT to provide adequate treatment and care to patients with amyloidosis
Paolo Milani, MD, PhD, Amyloidosis Research and Treatment Center, Pavia, Italy, emphasizes the importance of using a multidisciplinary team (MDT) in the care of patients with AL amyloidosis. Dr Milani explains that specialists including cardiologists, nephrologists, and neurologists are essential to provide adequate treatment and supportive care. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
